Skip to content
Screener

Tempus AI, Inc. TEM Price / book

Price / book at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
1.2×+0.1×
NeoGenomics logo
NeoGenomicsNEO
2.4×+1.3×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
25.5×-9.9×
IQVIA logo
IQVIAIQV
5.2×+0.5×
Guardant Health logo
Guardant HealthGH
36.8×
Natera, Inc. logo
Natera, Inc.NTRA
21.3×+2.5×

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M
CapEx-$22.5M-400%
Free cash flow-$30.1M

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%

Returns & leverage

See full
Return on equity-67.4%-16.0pp
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Calculated from Tempus AI, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s price / book?
Tempus AI, Inc. (TEM) reported price / book of 23.4× in Q2 2026.
How has Tempus AI, Inc.'s price / book changed year-over-year?
Tempus AI, Inc.'s price / book decreased by 38.8% year-over-year, from 38.2× to 23.4×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Tempus AI, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude